file,ref_number,ref_text,doi,doi_url,titleDoi,firstAuthDoi,author_similarity,title_similarity
experiments/crc/ai_messages/high_complexity--crc_apc_impact_2020_3,[1],"Clevers H, Nusse R. 2012. Cell. Wnt/β-Catenin Signaling and Disease.",10.1016/j.cell.2012.05.012,https://doi.org/10.1016/j.cell.2012.05.012,Wnt/β-Catenin Signaling and Disease,Clevers,100,100
experiments/crc/ai_messages/high_complexity--crc_apc_impact_2020_3,[2],Compton CC. 2007. J Clin Oncol. Optimal Pathologic Staging: Defining Stage II Disease.,10.1158/1078-0432.ccr-07-1398,https://doi.org/10.1158/1078-0432.ccr-07-1398,Optimal Pathologic Staging: Defining Stage II Disease,Compton,100,100
experiments/crc/ai_messages/high_complexity--crc_apc_impact_2020_3,[3],"Franko J, et al. 2012. Ann Surg Oncol. Prognostic Value of Peritoneal Cancer Index and Small Bowel Involvement for Patients With Colorectal Carcinomatosis.",10.1245/s10434-009-0610-6,https://doi.org/10.1245/s10434-009-0610-6,CT Peritoneal Cancer Index in Colorectal Peritoneal Carcinomatosis,Yan,3,94
experiments/crc/ai_messages/high_complexity--crc_apc_impact_2020_3,[4],"Van Cutsem E, et al. 2016. Ann Oncol. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer.",10.1093/annonc/mdy355.001,https://doi.org/10.1093/annonc/mdy355.001,Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer ; A JSMO - ESMO initiative,Yoshino,8,84
experiments/crc/ai_messages/high_complexity--crc_apc_impact_2020_3,[5],"Longley DB, et al. 2003. Nat Rev Cancer. 5-Fluorouracil: mechanisms of action and clinical strategies.",10.1038/nrc1074,https://doi.org/10.1038/nrc1074,5-Fluorouracil: mechanisms of action and clinical strategies,Longley,100,100
experiments/crc/ai_messages/high_complexity--crc_apc_impact_2020_3,[6],"Quail DF, Joyce JA. 2013. Nat Med. Microenvironmental regulation of tumor progression and metastasis.",10.1038/nm.3394,https://doi.org/10.1038/nm.3394,Microenvironmental regulation of tumor progression and metastasis,Quail,100,100
experiments/crc/ai_messages/high_complexity--crc_apc_impact_2020_3,[7],"Gajewski TF, et al. 2013. Nat Immunol. Cancer immunotherapy strategies based on overcoming barriers within the tumor microenvironment.",10.1016/j.coi.2013.02.009,https://doi.org/10.1016/j.coi.2013.02.009,Cancer immunotherapy strategies based on overcoming barriers within the tumor microenvironment,Gajewski,100,100
